Therapeutics Refresher Weekend
Date: 18/05/2019 - 19/05/2019
Venue: ACO, 374 Cardigan Street, Carlton, VIC, 3053
Provider: Australian College of Optometry
Contact: Liz Salvatore, [E] cpd@aco.org.au, [P] 03 9349 7477
Learning Objectives
- Classify allergic eye disease and be aware of the diagnostic signs that are associated with each category
- Recognise the clinical features of allergic eye disease and discuss the criteria for referral
- Causes of corneal ulceration
- List the risk factors, causes, clinical features, differential diagnostic signs that are characteristic of microbial keratitis (MK), laboratory investigations that help a clinician identify the pathogen and the treatment of the condition
- Demonstrate an understanding of the challenges of antibiotic sensitivity and resistance
- Discuss the role of steroids in the management of MK
- Understand the causes, pathogenesis and distinguishing clinical features of episcleritis, scleritis as well as systemic diseases that are associated with the conditions
- Explain the medical treatment of episcleritis and scleritis
- List some laboratory investigations that are useful in the diagnosis of episcleritis and scleritis
- Discuss the importance of acute anterior uveitis (AAU) and its association with HLA-B27 status and list some systemic conditions that are classified as HLA-B27 associated AAU entities
- Describe the clinical features of herpes simplex viral keratouveitis, herpes zoster ophthalmicus (HZO), Fuchs hetereochromic uveitis, Possner-Schlossman syndrome and uveitis-glaucoma-hyphaema syndrome
- Explain the medical management of acute and chronic anterior uveitis
- Understand the causes and clinical features of intermediate uveitisv
- Understand the possible causes of posterior uveitis
- Be familiar with the treatment options for intermediate uveitis and posterior uveitis
- List some useful laboratory investigations that assist in the diagnosis of intermediate uveitis
- Explain the treatment regimen for intermediate and posterior uveitis
- Demonstrate an awareness of primary ocular causes, secondary ocular causes and systemic causes of retinal vasculitis
- Contrast the clinical features of the various ‘white dot’ syndromes.
- Identify the morphological and functional features of optic neuropathies
- Recognise the differences between papilloedema and disc swelling
- Understand the clinical manifestations of a variety of inflammatory optic neuropathies
- Explain the relationship between optic neuritis and multiple sclerosis (MS)
- Describe the clinical signs that enable one to distinguish between true disc swelling and ‘pseudo’ disc swelling
- Demonstrate an awareness of the difference between unilateral versus bilateral causes of disc swelling
- List the causes of inflammatory optic neuropathy and the differential diagnosis of the condition
- Demonstrate an understanding of the management of optic neuritis
- List the features of temporal arteritis and recognise the need for urgent referral of the condition.
- Explain the relevance of intraocular hypertension in the overall diagnosis and management of glaucoma, with particular reference to relevant clinical trials
- Use the common glaucoma risk calculators to help plan a course of management for a patient
- List the roles that spectral domain OCT (SD-OCT) plays in the management of glaucoma
- Discuss the benefits of SD-OCT in monitoring the progression of glaucoma
- Understand the definition, epidemiology and pathophysiology of angle closure
- Identify the various stages of angle closure according to the International Society of Geographical and Epidemiologic Ophthalmology (ISGEO) classification of the condition
- Define normal tension glaucoma (NTG) and understand the causes of and the conditions that masquerade as NTG
- Explain the detailed examination and investigations that are warranted before a diagnosis of NTG can be made
- Explain the approaches to treatment of NTG
- Describe the approaches that are taken to reduce intraocular pressure (IOP)
- Explain the indications for a particular mode of treatment as well as the appropriate choice of drug
- Demonstrate an understanding of the essential role of selective laser trabeculoplasty (SLT) in the management of glaucoma
- 7. List some new and interesting approaches to the treatment of glaucoma, including: - iStent in conjunction with cataract surgery - New potential therapeutic targets for medication - Neuroprotective agents - Lifestyle modifications for glaucoma patients - XEN Gel Stent
Max points awarded: 27.00
Session Information
Name |
---|
Allergic Eye Disease, Infective Conjunctivitis and Microbial Keratitis |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
Yes |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
4.50 |
Name |
---|
Episcleritis, Scleritis and Anterior uveitis |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
Yes |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
4.50 |
Name |
---|
Intermediate uveitis and posterior uveitis |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
Yes |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
4.50 |
Name |
---|
Optic Neuropathy |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
Yes |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
4.50 |
Name |
---|
Glaucoma |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
Yes |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
4.50 |
Name |
---|
Glaucoma |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
Yes |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
4.50 |
Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
---|---|---|---|---|
Allergic Eye Disease, Infective Conjunctivitis and Microbial Keratitis | Face to Face with Assessment | Yes | No | 4.50 |
Episcleritis, Scleritis and Anterior uveitis | Face to Face with Assessment | Yes | No | 4.50 |
Intermediate uveitis and posterior uveitis | Face to Face with Assessment | Yes | No | 4.50 |
Optic Neuropathy | Face to Face with Assessment | Yes | No | 4.50 |
Glaucoma | Face to Face with Assessment | Yes | No | 4.50 |
Glaucoma | Face to Face with Assessment | Yes | No | 4.50 |